Rx&D has an effective and engaged Board of Directors that enables member companies to achieve common objectives.
Michael Tremblay, President, Astellas Pharma Canada, Inc.
Frédéric Fasano, Chief Executive Officer, Servier Canada Inc.
John Helou, President, Pfizer Canada Inc.
Paul Lirette, President, Canada Pharmaceuticals, GlaxoSmithKline Inc.
Russell Williams, Canada’s Research-Based Pharmaceutical Companies (Rx&D)
Mark Beaudet, President, Paladin Labs Inc.
Ed Gudaitis, General Manager, Gilead Sciences Canada Inc.
Chris Halyk, President, Janssen Inc.
Stéphane Lassignardie, General Manager, AbbVie Corporation
Lisa Matar, President & General Manager, Eli Lilly Canada Inc.
Ronnie Miller, President & CEO, Hoffmann-La Roche Limited
Dr. Nawal Peacock, President & General Manager, Bristol-Myers Squibb Canada
Allison Rosenthal, General Manager, Otsuka Canada Pharmaceutical Inc. (OCPI)